(-0.03%) 5 306.49 points
(0.02%) 39 916 points
(-0.09%) 16 727 points
(0.76%) $79.23
(2.94%) $2.49
(-0.41%) $2 385.00
(0.46%) $29.87
(-0.21%) $1 067.90
(0.17%) $0.920
(0.32%) $10.70
(0.09%) $0.789
(0.16%) $90.83
@ $1.280
Issued: 13 Feb 2024 @ 09:30
Return: 196.09%
Previous signal: Feb 12 - 14:52
Previous signal:
Return: -3.76 %
Live Chart Being Loaded With Signals
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract...
Stats | |
---|---|
Today's Volume | 261 386 |
Average Volume | 784 231 |
Market Cap | 878.14M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.250 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.65 |
ATR14 | $0.00900 (0.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Weber Darin J. | Sell | 800 | Class A Ordinary Shares |
2024-04-22 | Weber Darin J. | Sell | 16 438 | Class A Ordinary Shares |
2024-04-16 | Weber Darin J. | Sell | 17 238 | Class A Ordinary Shares |
2024-04-01 | Weber Darin J. | Sell | 300 | Class A Ordinary Shares |
2024-04-12 | Weber Darin J. | Sell | 84 103 | Class A Ordinary Shares |
INSIDER POWER |
---|
-30.90 |
Last 96 transactions |
Buy: 21 807 248 | Sell: 30 162 499 |
Volume Correlation
ProKidney Corp. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ProKidney Corp. Correlation - Currency/Commodity
ProKidney Corp. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-3.17M (0.00 %) |
EPS: | $-0.570 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-3.17M (0.00 %) |
EPS: | $-0.570 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-3.04M (0.00 %) |
EPS: | $-2.41 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.296 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators